Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Preferred Dividend Payments (2020 - 2021)

HCW Biologics (HCWB) has disclosed Preferred Dividend Payments for 2 consecutive years, with $482662.0 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Preferred Dividend Payments rose 72.51% year-over-year to $482662.0, compared with a TTM value of $960020.0 through Jun 2022, down 42.59%, and an annual FY2020 reading of $1.3 million, changed N/A over the prior year.
  • Preferred Dividend Payments was $482662.0 for Q2 2021 at HCW Biologics, up from $477358.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $482662.0 in Q2 2021 and bottomed at $279786.0 in Q2 2020.